Home LiteratureArticle Details
PMID: 9765441 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.

Journal of virology ·Vol. 72 ·No. 11 ·1998-11-00 ·Pages 8961-70

Granger SW, Fan H

Abstract

The enhancer sequences in the Moloney murine leukemia virus (M-MuLV) long terminal repeat (LTR) are of considerable interest since they are crucial for virus replication and the ability of the virus to induce T lymphomas. While extensive studies have identified numerous nuclear factors that can potentially bind to M-MuLV enhancer DNA in vitro, it has not been made clear which of these factors are bound in vivo. To address this problem, we carried out in vivo footprinting of the M-MuLV enhancer in infected cells by in vivo treatment with dimethyl sulfate (DMS) followed by visualization through ligation-mediated PCR (LMPCR) and gel electrophoresis. In vivo DMS-LMPCR footprinting of the upstream LTR revealed evidence for factor binding at several previously characterized motifs. In particular, protection of guanines in the central LVb/Ets and Core sites within the 75-bp repeats was detected in infected NIH 3T3 fibroblasts, Ti-6 lymphoid cells, and thymic tumor cells. In contrast, factor binding at the NF-1 sites was found in infected fibroblasts but not in T-lymphoid cells. These results are consistent with the results of previous experiments indicating the importance of the LVb/Ets and Core sequences for many retroviruses and the biological importance especially of the NF-1 sites in fibroblasts and T-lymphoid cells. No evidence for factor binding to the glucocorticoid responsive element and LVa sites was found. Additional sites of protein binding included a region in the GC-rich sequences downstream of the 75-bp repeats (only in fibroblasts), a hypersensitive guanine on the minus strand in the LVc site (only in T-lymphoid cells), and a region upstream of the 75-bp repeats. These experiments provide concrete evidence for the differential in vivo binding of nuclear factors to the M-MuLV enhancers in different cell types.

MeSH Terms
3T3 Cells Animals Base Sequence Binding Sites/genetics Cell Line Cell Nucleus/metabolism,virology DNA Footprinting DNA Methylation DNA Primers/genetics DNA, Viral/chemistry,genetics,metabolism Enhancer Elements, Genetic Genes, Viral Mice Molecular Sequence Data Moloney murine leukemia virus/genetics,pathogenicity,physiology Nuclear Proteins/metabolism Polymerase Chain Reaction Proviruses/genetics,pathogenicity,physiology Repetitive Sequences, Nucleic Acid T-Lymphocytes/metabolism,virology Virus Replication/genetics
Chemicals
DNA Primers DNA, Viral Nuclear Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Granger S W
Department of Molecular Biology and Biochemistry and Cancer Research Institute, University of California, Irvine, California 92697-3900, USA.
Fan H
References (50)
50 references, click to expand
  1. New class of leukemogenic ecotropic recombinant murine leukemia virus isolated from radiation-induced thymomas of C57BL/6 mice.
    J Virol. 1983 Feb;45(2):565-75 PMID: 6300420
  2. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR.
    Science. 1989 Nov 10;246(4931):780-6 PMID: 2814500
  3. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.
    Proc Natl Acad Sci U S A. 1983 Jul;80(14):4408-11 PMID: 6308622
  4. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat.
    Nature. 1984 Mar 29-Apr 4;308(5958):467-70 PMID: 6323995
  5. A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus.
    J Virol. 1984 Oct;52(1):248-54 PMID: 6090701
  6. Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses.
    J Virol. 1984 Nov;52(2):448-56 PMID: 6092670
  7. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential.
    J Virol. 1984 Dec;52(3):945-52 PMID: 6092722
  8. Genomic sequencing and methylation analysis by ligation mediated PCR.
    Science. 1989 Nov 10;246(4931):810-3 PMID: 2814502
  9. Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design.
    J Virol. 1990 Feb;64(2):534-42 PMID: 2153223
  10. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
    J Virol. 1990 Feb;64(2):543-50 PMID: 2104942
  11. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
    Genes Dev. 1990 Feb;4(2):233-42 PMID: 2338244
  12. Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus.
    Genes Dev. 1990 Apr;4(4):667-79 PMID: 2163347
  13. Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic mice.
    J Virol. 1990 Aug;64(8):3701-11 PMID: 2164592
  14. Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability.
    Proc Natl Acad Sci U S A. 1990 Nov;87(21):8252-6 PMID: 2236038
  15. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences.
    J Virol. 1991 Jan;65(1):42-50 PMID: 1985206
  16. Nuclear factor-1 (NF-1) binds to multiple sites within the transcriptional enhancer of Moloney murine leukemia virus.
    FEBS Lett. 1990 Dec 17;277(1-2):209-11 PMID: 2269357
  17. Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines.
    J Virol. 1991 Apr;65(4):1991-9 PMID: 1848314
  18. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.
    J Virol. 1991 Oct;65(10):5357-63 PMID: 1895389
  19. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus.
    Mol Cell Biol. 1992 Jan;12(1):38-44 PMID: 1309593
  20. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers.
    Mol Cell Biol. 1992 Jan;12(1):89-102 PMID: 1309596
  21. Effects of different DNA polymerases in ligation-mediated PCR: enhanced genomic sequencing and in vivo footprinting.
    Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):1021-5 PMID: 1736283
  22. Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif.
    Genes Dev. 1992 Jun;6(6):975-90 PMID: 1592264
  23. Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells.
    Jpn J Cancer Res. 1992 Jul;83(7):714-22 PMID: 1325429
  24. Approaches to characterize protein-DNA interactions in vivo.
    Crit Rev Eukaryot Gene Expr. 1993;3(1):1-29 PMID: 8439708
  25. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.
    J Virol. 1993 Apr;67(4):1967-75 PMID: 8445718
  26. Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers.
    J Virol. 1993 Apr;67(4):1976-86 PMID: 8445719
  27. A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes.
    J Virol. 1993 Apr;67(4):2298-304 PMID: 8383242
  28. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.
    Mol Cell Biol. 1993 Jun;13(6):3324-39 PMID: 8497254
  29. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.
    Science. 1993 Aug 20;261(5124):1041-4 PMID: 8351518
  30. Purification of SEF1 proteins binding to transcriptional enhancer elements active in T lymphocytes.
    J Biol Chem. 1993 Oct 15;268(29):21946-54 PMID: 8408051
  31. In vivo footprinting and genomic sequencing by ligation-mediated PCR.
    Anal Biochem. 1993 Sep;213(2):179-93 PMID: 8238889
  32. Cooperative binding of Ets-1 and core binding factor to DNA.
    Mol Cell Biol. 1994 Jan;14(1):840-50 PMID: 8264651
  33. Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities.
    J Virol. 1994 May;68(5):3308-16 PMID: 8151791
  34. In vivo DNA footprinting by linear amplification.
    Methods Mol Biol. 1994;31:317-29 PMID: 7921028
  35. Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer.
    Mol Cell Biol. 1994 Nov;14(11):7569-80 PMID: 7935472
  36. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
    J Virol. 1997 Feb;71(2):1196-206 PMID: 8995642
  37. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL.
    Nucleic Acids Res. 1998 Jan 1;26(1):362-7 PMID: 9399875
  38. Long terminal repeat of Friend-MCF virus contains the sequence responsible for erythroid leukemia.
    Virology. 1985 Feb;141(1):30-42 PMID: 3856371
  39. Differential transcription from the long terminal repeats of integrated avian leukosis virus DNA.
    J Virol. 1986 Nov;60(2):497-505 PMID: 3021984
  40. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.
    J Virol. 1987 Mar;61(3):693-700 PMID: 3468264
  41. Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats.
    J Virol. 1987 Apr;61(4):1067-72 PMID: 3029400
  42. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer.
    Mol Cell Biol. 1987 Mar;7(3):1101-10 PMID: 3561410
  43. Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses.
    Genes Dev. 1987 Apr;1(2):133-46 PMID: 2824279
  44. Constitutive and metal-inducible protein:DNA interactions at the mouse metallothionein I promoter examined by in vivo and in vitro footprinting.
    Genes Dev. 1988 Apr;2(4):412-27 PMID: 3371659
  45. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3.
    Mol Cell Biol. 1988 Apr;8(4):1625-37 PMID: 2837650
  46. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
    J Virol. 1989 Jan;63(1):328-37 PMID: 2783259
  47. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element.
    J Virol. 1989 Jan;63(1):76-84 PMID: 2535754
  48. Transcription factors AP-3 and AP-2 interact with the SV40 enhancer in a mutually exclusive manner.
    EMBO J. 1989 May;8(5):1455-60 PMID: 2548845
  49. Eukaryotic transcriptional regulatory proteins.
    Annu Rev Biochem. 1989;58:799-839 PMID: 2673023
  50. Thymotropism of murine leukemia virus is conferred by its long terminal repeat.
    Proc Natl Acad Sci U S A. 1983 Jul;80(14):4203-7 PMID: 6308605
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1998-11-00
Pages
8961-70
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC110313
Subset
IM
Grants
NCI NIH HHS · R01 CA032455 · United States
NCI NIH HHS · T32 CA009054 · United States
NCI NIH HHS · 5 T32 CA09054 · United States
NCI NIH HHS · CA32455 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]